List of Immunovative Therapies patents

Patents where

Current Assignee

Name

Immunovative Therapies

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7435592 Compositions for allogeneic cell therapy	Patent 7435592 was granted and assigned to Immunovative Therapies on October, 2008 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	7435592	October 14, 2008
‌ US Patent 8354276 T-cell compositions that elicit type I cytokine response	Patent 8354276 was granted and assigned to Immunovative Therapies on January, 2013 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	8354276	January 15, 2013
‌ US Patent 7402431 T-cell therapy formulation	Patent 7402431 was granted and assigned to Immunovative Therapies on July, 2008 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	7402431	July 22, 2008
‌ US Patent 9272001 Ablative immunotherapy	Patent 9272001 was granted and assigned to Immunovative Therapies on March, 2016 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	9272001	March 1, 2016
‌ US Patent 8679841 Allogeneic cell compositions with cross-linked CD3/CD28	Patent 8679841 was granted and assigned to Immunovative Therapies on March, 2014 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	8679841	March 25, 2014
‌ US Patent 7678572 Methods for preparing T-cells for cell therapy	Patent 7678572 was granted and assigned to Immunovative Therapies on March, 2010 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	7678572	March 16, 2010
‌ US Patent 7956164 Device for enhancing immunostimulatory capabilities of T-cells	Patent 7956164 was granted and assigned to Immunovative Therapies on June, 2011 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	7956164	June 7, 2011
‌ US Patent 9593308 Device for enhancing immunostimulatory capabilities of T-cells	Patent 9593308 was granted and assigned to Immunovative Therapies on March, 2017 by the United States Patent and Trademark Office.	Immunovative Therapies	Immunovative Therapies	United States Patent and Trademark Office	9593308	March 14, 2017
‌ US Patent 9233156 Induction of IL-12 using immunotherapy	Patent 9233156 was granted and assigned to Immunovative Therapies on January, 2016 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	9233156	January 12, 2016
‌ US Patent 8012750 T-cell activation device	Patent 8012750 was granted and assigned to Immunovative Therapies on September, 2011 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	8012750	September 6, 2011
‌ US Patent 7592431 Biodegradable T-cell Activation device	Patent 7592431 was granted and assigned to Immunovative Therapies on September, 2009 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	7592431	September 22, 2009
‌ US Patent 9320794 Ablative immunotherapy	Patent 9320794 was granted and assigned to Immunovative Therapies on April, 2016 by the United States Patent and Trademark Office.	Immunovative Therapies	Immunovative Therapies	United States Patent and Trademark Office	9320794	April 26, 2016
‌ US Patent 9695397 Th1 vaccination priming for active immunotherapy	Patent 9695397 was granted and assigned to Immunovative Therapies on July, 2017 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	9695397	July 4, 2017
‌ US Patent 10318712 Automated device for biologic drug distribution	Patent 10318712 was granted and assigned to Immunovative Therapies on June, 2019 by the United States Patent and Trademark Office.	Immunovative Therapies	Immunovative Therapies	United States Patent and Trademark Office	10318712	June 11, 2019
‌ US Patent 9301977 Method for allogeneic cell therapy	Patent 9301977 was granted and assigned to Immunovative Therapies on April, 2016 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	9301977	April 5, 2016
‌ US Patent 9511127 Method to formulate T-cells	Patent 9511127 was granted and assigned to Immunovative Therapies on December, 2016 by the United States Patent and Trademark Office.	Immunovative Therapies	Immunovative Therapies	United States Patent and Trademark Office	9511127	December 6, 2016
‌ US Patent 9352001 Method for stimulating a host immune system	Patent 9352001 was granted and assigned to Immunovative Therapies on May, 2016 by the United States Patent and Trademark Office.	Immunovative Therapies	Immunovative Therapies	United States Patent and Trademark Office	9352001	May 31, 2016
‌ US Patent 8778678 Composition of activated CD4 cells	Patent 8778678 was granted and assigned to Immunovative Therapies on July, 2014 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	8778678	July 15, 2014
‌ US Patent 10272143 Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome	Patent 10272143 was granted and assigned to Immunovative Therapies on April, 2019 by the United States Patent and Trademark Office.	Immunovative Therapies	Immunovative Therapies	United States Patent and Trademark Office	10272143	April 30, 2019
‌ US Patent 8728534 Method for stimulating a host immune system	Patent 8728534 was granted and assigned to Immunovative Therapies on May, 2014 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	8728534	May 20, 2014
‌ US Patent 8883974 Device for enhancing immunostimulatory capabilities of T-cells	Patent 8883974 was granted and assigned to Immunovative Therapies on November, 2014 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	8883974	November 11, 2014
‌ US Patent 7943180 Method for stimulating a host immune system by administering an allogeneic cell material	Patent 7943180 was granted and assigned to Immunovative Therapies on May, 2011 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	7943180	May 17, 2011
‌ US Patent 7972594 Ablative immunotherapy	Patent 7972594 was granted and assigned to Immunovative Therapies on July, 2011 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	7972594	July 5, 2011
‌ US Patent 8748580 Device for enhancing immunostimulatory capabilities of T-cells	Patent 8748580 was granted and assigned to Immunovative Therapies on June, 2014 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	8748580	June 10, 2014
‌ US Patent 9782463 Method for allogeneic cell therapy	Patent 9782463 was granted and assigned to Immunovative Therapies on October, 2017 by the United States Patent and Trademark Office.		Immunovative Therapies	United States Patent and Trademark Office	9782463	October 10, 2017

Results per page:

34 results

0 selected

34 results

0 selected